- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patent holdings for IPC class C07K 16/00
Total number of patents in this class: 11430
10-year publication summary
|
876
|
814
|
881
|
827
|
785
|
753
|
625
|
487
|
439
|
260
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4701 |
289 |
| Amgen Inc. | 4427 |
260 |
| Genentech, Inc. | 4104 |
193 |
| Chugai Seiyaku Kabushiki Kaisha | 1423 |
165 |
| F. Hoffmann-La Roche AG | 7837 |
156 |
| Hoffmann-La Roche Inc. | 3793 |
147 |
| The Regents of the University of California | 20745 |
116 |
| Novartis AG | 10262 |
100 |
| Abbvie Inc. | 1836 |
93 |
| Xencor, Inc. | 413 |
78 |
| Ablynx N.V. | 426 |
73 |
| Bristol-myers Squibb Company | 4742 |
69 |
| Janssen Biotech, Inc. | 1764 |
69 |
| Sanofi | 4301 |
64 |
| Pfizer Inc. | 3386 |
62 |
| MedImmune, LLC | 498 |
58 |
| Cytiva BioProcess R&D AB | 322 |
58 |
| Zymeworks Inc. | 253 |
55 |
| Daiichi Sankyo Company, Limited | 1890 |
51 |
| Kymab Limited | 275 |
51 |
| Other owners | 9223 |